Beylikduzu State Hospital, Istanbul, Turkey.
Department of Urology, Catalca Ilyas Cokay State Hospital, Istanbul, Turkey.
Aging Male. 2020 Dec;23(5):533-537. doi: 10.1080/13685538.2018.1541133. Epub 2018 Nov 23.
Transurethral resection of the prostate (TURP) is the gold standard method for surgical treatment of benign prostatic hyperplasia (BPH). So, the complications of TURP is important, in which erectile dysfunction is the most important. The aim of the present study is to evaluate erectile dysfunction in patients undergoing TURP treatment for BPH and investigate the correlation between metabolic syndrome and erectile dysfunction.
This study included 120 patients who underwent surgery for BPH at Beylikdüzü State Hospital and Okmeydani Training and Research Hospital. IIEF-5 form was administered to the patients before the surgery and six months after the surgery. The Student's -test, Wilcoxon, and chi-square test were used in the statistical analysis.
The patients were investigated by IIEF-5 scoring into three groups (severe, moderate, and non-ED (erectyl disfunction)-mild). The statistical analysis of IIEF-5 form administered to 120 patients who underwent surgery did not show any significant difference before surgery and six months after surgery ( > 0.05). Metabolic syndrome and erectile dysfunction correlation were examined, and a significant correlation was obtained between metabolic syndrome and severe erectile dysfunction ( < 0.05).
IIEF-5 results administered before and after surgery showed no significant difference. The study showed that patients with metabolic syndrome have a higher probability of having erectile dysfunction after TURP compared to patients without metabolic syndrome. Moreover, post-surgery, patients with metabolic syndrome seemed to be affected negatively regarding erectile dysfunction compared to patients with no metabolic syndrome.
经尿道前列腺切除术(TURP)是治疗良性前列腺增生(BPH)的金标准手术方法。因此,TURP 的并发症很重要,其中勃起功能障碍是最重要的。本研究旨在评估接受 TURP 治疗的 BPH 患者的勃起功能障碍,并研究代谢综合征与勃起功能障碍之间的相关性。
本研究纳入了在贝伊勒哲乌市立医院和 Okmeydani 培训与研究医院接受手术治疗的 120 例 BPH 患者。在手术前和手术后 6 个月,患者接受了 IIEF-5 表格评估。统计分析采用 Student's -test、Wilcoxon 和卡方检验。
通过 IIEF-5 评分,将患者分为三组(严重、中度和非 ED(勃起功能障碍)-轻度)。对 120 例接受手术的患者进行的 IIEF-5 表格分析显示,手术前后无统计学差异(>0.05)。检查了代谢综合征与勃起功能障碍的相关性,发现代谢综合征与严重勃起功能障碍之间存在显著相关性(<0.05)。
手术前后的 IIEF-5 结果无显著差异。该研究表明,与无代谢综合征的患者相比,患有代谢综合征的患者在接受 TURP 后发生勃起功能障碍的可能性更高。此外,与无代谢综合征的患者相比,术后患有代谢综合征的患者似乎在勃起功能障碍方面受到负面影响。